Investor Information

2006 Press Releases

Print Page Print | E-mail Page E-mail Page | RSS Feeds RSS | E-mail Alerts Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet

The information and content in this site has been released in the past by Express Scripts Holding Company or its predecessor and wholly-owned subsidiary, Express Scripts, Inc. (together, Express Scripts). These contents may no longer be current. The passage of time can render information stale, and you should not rely on the continued accuracy of any such material beyond the date of issuance. On the date released, some of the contents in this site may have contained statements that were then "forward-looking statements," based upon then current expectations, forecasts and assumptions that involved risks and uncertainties, then enumerated by Express Scripts that could cause actual outcomes and results to differ materially. To the extent any information is forward-looking, it is intended to comply with the safe harbor for forward-looking information as of the date of issuance (for more information, view our forward-looking statement). Express Scripts disclaims any intention or obligation to update or revise the contents of this site, including but not limited to any forward-looking statements made at the time the information was first released, whether as a result of new information, future events or otherwise.

Keyword Search


Archived Press Releases
2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006
12/20/2006Express Scripts Comments on Caremark/CVS HSR Announcement
ST. LOUIS, Dec. 20 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today issued the following statement related to the announcement by Caremark Rx, Inc., (NYSE: CMX): "As we expected, the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act has expired for CVS Corporation (NYSE: CVS). We said on December 18th that we anticipate the Express Scripts transaction with Caremark would be completed in the third quarter of 2007. The super... 
12/18/2006Express Scripts Proposes to Acquire Caremark for $58.50 Per Share in Cash and Stock
Transaction Valued at Approximately $26 Billion Premium Approximately 22% Combination to Create World's Preeminent Pharmacy Benefit Management Company Annual Cost Synergies Expected to be Approximately $500 Million ST. LOUIS, Dec. 18 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that it is proposing to acquire all of the outstanding shares of Caremark Rx, Inc., (NYSE: CMX) for $29.25 in cash and 0.426 shares of E... 
12/14/2006Express Scripts to Present at the JP Morgan Healthcare Conference
ST. LOUIS, Dec. 14 /PRNewswire-FirstCall/ -- David Myers, Vice President Investor Relations of Express Scripts, Inc. (Nasdaq: ESRX) is scheduled to present at the 25th Annual JP Morgan Healthcare Conference on January 8, 2007 at 1:30 p.m. PST (4:30 p.m. EST) at The Westin St. Francis in San Francisco, California. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com . ... 
11/14/2006Express Scripts Provides 2007 Earnings Guidance
Reflects Growth of 20% to 24% ST. LOUIS, Nov. 14 /PRNewswire-FirstCall/ -- Express Scripts (Nasdaq: ESRX) announced today that it believes its financial performance will continue to benefit from growth in generic utilization, home delivery, and specialty pharmacy management; lower retail and home delivery drug purchasing costs; improved formulary compliance with preferred, lower-cost brand drugs; increased productivity; and capital structure improvements. As a ... 
11/10/2006Express Scripts, Inc. Announces 2007 Earnings Guidance Conference Call
ST. LOUIS, Nov. 10 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its 2007 earnings guidance on Tuesday, November 14, 2006 before the market opens and hold a conference call on this day to discuss this guidance at 8:30 a.m. Central (9:30 a.m. Eastern). This call is being webcast and can be accessed at Express Scripts' web site at http://www.express-s... 
11/08/2006Express Scripts to Present at Investor Conferences
ST. LOUIS, Nov. 8 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following conferences: Credit Suisse Health Care Conference on November 16, 2006 at 11:00 a.m. MST (1:00 p.m. EST) at The Arizona Biltmore Hotel in Phoenix, Arizona. Merrill Lynch Health Services Investor Conference on November 28, 2006 at 10:15 a.m. EST at the Waldorf Astoria Hotel in New York, NY. These presentations will also be broadcast via the Interne... 
10/24/2006Express Scripts Reports Record Third Quarter 2006 Earnings
2.5 Million Shares Repurchased During the Quarter Earnings Guidance Increased for 2006 ST. LOUIS, Oct. 24 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced third quarter net income of $114.7 million, or $0.83 per diluted share. This represents a 24 percent increase over $0.67 per diluted share last year, adjusted to exclude a $0.01 per diluted share non- recurring tax benefit. During the quarter, Express Scripts repu... 
09/28/2006New Web Tool Helps Consumers Uncover Generic Drug Alternatives
ST. LOUIS, Sept. 28 /PRNewswire-FirstCall/ -- With more than $10 billion in brand drugs going generic this year, consumers and health plans are cutting drug costs by as much as $60 on each prescription where a new generic is available. Consumers using brand drugs that aren't available as a generic can also get in on the savings. Potential alternatives to brand medications are often available and achieve a comparable therapeutic result to the brand at a lower cost. Uncovering ... 
09/27/2006Express Scripts, Inc. Announces Third Quarter 2006 Earnings Conference Call
ST. LOUIS, Sept. 27 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its third quarter earnings on Tuesday, October 24, 2006 after 3:00 p.m. Central Time. In addition, management will hold its quarterly conference call to discuss third quarter results on Wednesday, October 25, 2006 at 9:00 a.m. Central Time. This call is being webcast and can be accesse... 
09/18/2006Prescription Assistance Program Helps with Medicare Part D Doughnut Hole
ST. LOUIS, Sept. 18 /PRNewswire-FirstCall/ -- Nine months into the new Medicare Part D program, many beneficiaries are finding themselves in the program's "doughnut hole" coverage gap. Rx Outreach(SM), a patient assistance program (PAP) offered by pharmacy benefit manager Express Scripts, can help Medicare Part D beneficiaries in the "doughnut hole." Rx Outreach's PAP offers 90-day supplies of 110 primarily generic medications from more than 40 therapeutic classes to treat mos... 
08/29/2006Express Scripts to Present at Investor Conferences
ST. LOUIS, Aug. 29 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following conferences: Thomas Weisel Partners Healthcare Conference 2006 on September 6, 2006 at 10:55 a.m. EDT at the Four Seasons Hotel in Boston, MA. Bank of America 36th Annual Investment Conference on September 18, 2006 at 8:30 a.m. PDT (11:30 a.m. EDT) at the Ritz Carlton in San Francisco, CA. These presentations will be broadcast via the Inter... 
08/02/2006Express Scripts' CEO to Adopt 10b5-1 Plan
Reiterates 2006 Earnings GuidanceST. LOUIS, Aug 02, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today that George Paz, the Company's president, chief executive officer and chairman, plans to adopt a new prearranged trading plan under Rule 10b5-1 of the Securities and Exchange Act of 1934. Rule 10b5-1 permits officers and directors of public companies to adopt predetermined plans for selling specified amounts of stock. No transactio... 
07/26/2006Express Scripts Reports Second Quarter 2006 Earnings
9.5 Million Shares Repurchased During the Quarter Earnings Guidance Increased for 2006 ST. LOUIS, July 26 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced second quarter net income of $107.8 million, or $0.75 per diluted share. This represents a 25 percent increase over $0.60 per diluted share last year, adjusted to exclude an $0.08 per diluted share non- recurring tax benefit. During the quarter, Express Scripts re... 
06/29/2006Express Scripts, Inc. Announces Second Quarter 2006 Earnings Conference Call
ST. LOUIS, June 29 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its second quarter earnings on Wednesday, July 26, 2006 after 3:00 p.m. Central Time. In addition, management will hold its quarterly conference call to discuss second quarter results on Thursday, July 27, 2006 at 9:00 a.m. Central Time. This call is being webcast and can be accessed a... 
06/07/2006Express Scripts to Present at Investor Conferences
ST. LOUIS, June 7, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following conferences: Goldman Sachs 27th Annual Global Healthcare Conference on June 15, 2006 at 9:20 a.m. PDT (12:20 p.m. EDT) at the Ritz-Carlton in Dana Point, CA. William Blair 26th Annual Growth Stock Conference on June 27, 2006 at 9:50 a.m. CDT (10:50 a.m. EDT) at the Four Seasons Hotel in Chicago, IL. These presentations will be... 
06/07/2006Specialty Biotech Drug Spending Skyrockets
Cost Control Strategies Begin to Show Success ST. LOUIS, June 7, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Spending on America's most popular class of biotech drugs -- those used to treat inflammatory diseases -- increased 33.9 percent in 2005, according to the 2006 Express Scripts Specialty Drug Trend Report. The company is one of the nation's largest managers of pharmacy benefit plans, serving more than 55 million people. Although the class includes only four drugs -- th... 
06/06/2006$24.7 Billion in Generic Savings Available This Year
Driven by Blockbuster Brands Going Generic ST. LOUIS, June 6 /PRNewswire/ -- Generic drugs could save U.S. consumers $24.7 billion this year alone, according to a report issued today by Express Scripts, one of the nation's largest managers of pharmacy benefit plans. The report examined the clinical potential for greater generic drug use in six major drug-therapy classes used to treat common conditions like stomach ulcers, inflammation, depression, high blood press... 
05/24/2006Generic Drugs First for Millions
ST. LOUIS, May 24 /PRNewswire-FirstCall/ -- For millions of Americans, getting a new prescription increasingly means first trying a lower cost generic medicine before using a more expensive brand drug. Today, Express Scripts reported that 14 million consumers in pharmacy benefit plans it manages are now covered by programs that support using a generic as a first treatment option. The company said the figure represents a five-fold increase in the number of pharmacy benefit plan... 
05/09/2006Express Scripts to Present at the Bank of America Health Care Conference
ST. LOUIS, May 9, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the Bank of America Health Care Conference on May 17, 2006 at 8:00 a.m. PDT (11:00 a.m. EDT) at The Four Seasons Hotel in Las Vegas, Nevada. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com . RealPlayer or Windows Media Play... 
05/01/2006Savings to Follow Generic Zocor Court Ruling
Express Scripts Reaffirms 2006 Earnings GuidanceST. LOUIS, May 1, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) commented today on the court's decision granting 180-day exclusivity for the generic version of Zocor, or simvastatin. During the 180-day exclusive period there will be two competing suppliers of simvastatin, which includes an authorized generic manufacturer. "Our clients will realize a significant reduction in the price of Zocor wh... 
04/26/2006Express Scripts Reports Solid First Quarter 2006 Earnings
ST. LOUIS, April 26 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced first quarter net income of $104.7 million, or $0.70 per diluted share. This compares to first quarter 2005 diluted earnings per share of $0.57, which included a $0.01 per diluted share non-recurring tax benefit. All per share amounts have been adjusted to reflect the Company's 2-for-1 stock split, which was effective June 24, 2005. "Our first quarter results reflect our continued focus ... 
04/25/2006Express Scripts' Research Earns Excellence Award
ST. LOUIS, April 25 /PRNewswire-FirstCall/ -- Express Scripts' "Effect of Patient Notification of Formulary Change on Formulary Adherence" research was selected as one of the three best articles published in the Journal of Managed Care Pharmacy (JMCP) in 2005. This honor marks the third year in a row Express Scripts has been recognized by the Academy of Managed Care Pharmacy for producing research ranked among the best scholarly work in managed care pharmacy. The randomized co... 
04/04/2006National Study Reveals Doubling in Type 2 Diabetes Prescriptions Among Children
-- Dramatic Four-Year-Increase a Leading Indicator of Future Health Care Cost Growth -- ST. LOUIS, April 4 /PRNewswire-FirstCall/ -- Express Scripts today announced results of a study of prescription claims for millions of U.S. children ages 5 to 19 revealing a four-year doubling in those taking medication typically used to treat or prevent Type 2 diabetes. This rapid increase, a rise from about 0.3 to 0.6 per thousand from 2002 to 2005, represents en... 
03/30/2006Express Scripts, Inc. Announces First Quarter 2006 Earnings Conference Call
ST. LOUIS, March 30 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its first quarter earnings on Wednesday, April 26, 2006 after 3:00 p.m. Central Time. In addition, management will hold its quarterly conference call to discuss first quarter results on Thursday, April 27, 2006 at 9:00 a.m. Central Time. This call is being webcast and can be accessed a... 
03/15/2006Express Scripts to Webcast Investor Meeting
ST. LOUIS, March 15 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will webcast its investor meeting beginning at 8:30 a.m. Mountain Time (11:30 a.m. Eastern Time) on Friday, April 7, 2006, at which management will make presentations regarding the Company followed by a tour of its Tempe Home Delivery Pharmacy. The presentation will be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at ht... 
03/03/2006Express Scripts' CEO Adopts 10b5-1 Plan
ST. LOUIS, March 3 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today that George Paz, the Company's president and chief executive officer, has adopted a prearranged trading plan under Rule 10b5-1 of the Securities and Exchange Act of 1934. Rule 10b5-1 permits officers and directors of public companies to adopt predetermined plans for selling specified amounts of stock. "While I believe we are well-positioned in the PBM sector and am excited about our p... 
02/28/2006Lower Cost Generic Drugs for Lower Income Consumers
ST. LOUIS, Feb. 28 /PRNewswire-FirstCall/ -- Lower income consumers now can pay less for more generic medications, with a doubling of the number of generic medications available through Rx Outreach, a generic patient assistance program. The broader coverage will increase the number of generic drugs offered to 107, effective March 1. The program offers drugs in 19 of the top 25 therapeutic classes. Rx Outreach saved 267,000 patients more than $61 million while filling 771,000 pre... 
02/22/2006Express Scripts Reports Record Fourth Quarter and Full Year 2005 Earnings
EBITDA Per Adjusted Claim up 37% to $1.53ST. LOUIS, Feb 22, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced record fourth quarter net income of $111 million, or $0.75 per diluted share. Excluding a fourth quarter charge of $0.02 per diluted share for the early retirement of debt, earnings per diluted share was $0.77, a 45% increase over $0.53 per diluted share reported for the same quarter last year. All per share amounts have been adj... 
02/20/2006Express Scripts to Present at Investor Conferences
ST. LOUIS, Feb. 20 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following conferences. These presentations will be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com . Citigroup 2006 Healthcare Conference on March 1, 2006 at 2:30 p.m. EST at the Mayflower Hotel in Washington, DC. SG Cowen Healthcare Conference on March 7, 2006 at 1... 
02/09/2006Study: Set Pharmacy Copays to Reduce Costs, Avoid Cost-Shifting with Generic Drugs
ST. LOUIS, Feb. 9 /PRNewswire-FirstCall/ -- Express Scripts research reveals how changes to prescription benefit copayments can reduce healthcare costs through greater use of generic drugs without shifting costs to consumers. "A study released today, based on an analysis of 2004 prescription claims, indicates a pharmacy benefit plan design that increases the differential between brand and generic copayments by $10 can expect to achieve a 3 to 4 percentage point increase in the gen... 
01/19/2006Express Scripts, Inc. Announces Fourth Quarter 2005 Earnings Conference Call
ST. LOUIS, Jan. 19 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today its intention to release its fourth quarter earnings on Wednesday, February 22, 2006 after 3:00 p.m. Central Time. In addition, management will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 23, 2006 at 9:00 a.m. Central Time. This call is being webcast and can be accessed at Express Scripts' web site at http://www.express-scripts.com/ in th... 
01/18/2006Generic Drug Info/Interview Resource for Journalists
Generic drugs promise to be one of the biggest, continuing health stories of 2006, with more than $11.3 billion (in sales) of brand drugs going generic. The biggest of these will be Zocor (simvastatin) at more than $3 billion in sales. For comprehensive background information on the generics opportunity and the billions that can be saved by using more generic drugs visit: http://www.express-scripts.com/pr/generics Our physician and pharmacy experts are also available to an... 
01/05/2006Express Scripts to Present at the JP Morgan Healthcare Conference - Note Change of Time
ST. LOUIS, Jan. 5 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the 24th Annual JP Morgan Healthcare Conference on January 9, 2006 at 11:00 a.m. PST (2:00 p.m. EST) at The Westin St. Francis in San Francisco, California. The Company previously released that it would present at 11:00 a.m. EST. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at h... 
01/03/2006Express Scripts to Present at the JP Morgan Healthcare Conference
ST. LOUIS, Jan. 3 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the 24th Annual JP Morgan Healthcare Conference on January 9, 2006 at 11:00 a.m. EST at The Westin St. Francis in San Francisco, California. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com . RealPlayer or Windows Media Player is needed to listen ...